source
- US drug shortages climb for third consecutive quarter, many rely on single suppliersThe latest data show that the count of medicines in shortage across the United States increased again in the most recent quarter, marking the third straight period of growth. Analysts note that ne…
- Takeda's zasocitinib clears scalp psoriasis in 75% of patients in phase 3 dataTakeda released updated results from its two phase 3 trials of the oral TYK2 inhibitor zasocitinib, enrolling a total of 1,801 patients with moderate-to-severe plaque psoriasis. The data showed th…